A case of a geriatric patient with thrombocytopenia after partial recovery from COVID-19.

Publication date: Sep 06, 2024

The global emergence of -COVID-19 has prompted rapid therapeutic and vaccine advancements; however, clinical evidence remains limited. With around a 50% fatality rate for COVID-19 patients with acute respiratory distress syndrome (ARDS), early intervention is crucial. This report details a severe case of post-COVID-19 thrombocytopenia in a 79-year-old man and emphasizes its critical nature. Despite negative initial COVID-19 test results, subsequent positive results led to treatment initiation, and severe thrombocytopenia persisted resulting in bleeding complications and death. Recognized as a hematological manifestation of COVID-19, thrombocytopenia in this geriatric patient highlights the need for extended post-COVID-19 monitoring and management. This underscores the importance of vigilance and timely intervention, especially in vulnerable populations, and emphasizes the need for further research to understand the intricate relationship between COVID-19 and thrombocytopenia.

Concepts Keywords
Covid Clinical
Early Covid
Thrombocytopenia Emergence
Vaccine Emphasizes
Geriatric
Global
Intervention
Partial
Patient
Post
Prompted
Rapid
Recovery
Severe
Thrombocytopenia

Semantics

Type Source Name
disease MESH thrombocytopenia
disease MESH COVID-19
disease MESH acute respiratory distress syndrome
disease IDO intervention
disease MESH bleeding
disease MESH complications
disease MESH death
disease MESH Long Covid

Original Article

(Visited 2 times, 1 visits today)